Laybon tablet for knee osteoarthritis pain
Part of Bones, joints & muscles clinical trials.
This study tests a new oral medication, Laybon Tab., for pain from knee osteoarthritis. It aims to see how well it works and how safe it is over time, potentially offering another treatment option for your knee pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have knee osteoarthritis (wear-and-tear arthritis in your knee). Your doctor can confirm this.
- You have had knee pain for at least 3 months and it is severe enough to need medication.
- On a 0 to 100 pain scale, your knee pain during movement is at least 40 out of 100.
- You can walk without help (using a cane or walker is okay if you have used it for at least 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.
This trial tests whether a herbal supplement helps people with osteoarthritis of the knee or hip feel less pain and move better. If you have moderate to severe pain and are able to walk, this study might be a good fit.
This study tests whether L-arginine, a natural amino acid, can help with knee pain from osteoarthritis. You might be eligible if you are 40–80 years old, have moderate osteoarthritis on X-ray, and have had knee pain for at least 3 months.
This study tests whether vitamin D combined with omega-3 or metformin can help with knee osteoarthritis pain. It aims to see if these supplements can reduce pain and improve knee function.
This trial tests a study drug called SL1002 to see if it reduces knee pain from osteoarthritis. It may be an option for people with chronic knee pain who haven't found enough relief from current treatments.
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.